Beauty Health ( NASDAQ: SKIN ) stock fell ~4% on 06 30, which also Canaccord Genuity cut its cost target on the California-based industry’s shares to $20 through $22, but maintained a Buy rating.
The SA Quant Ranking on SKIN is Hold , which usually takes into account factors such as development and profitability, among others factors. The rating is in comparison to the average Wall Road Analysts’ Rating of Strong Buy , in which 7 out of 11 experts call it a Strong Purchase.
YTD, Beauty Health’s stock has declined ~46% . The graph below shows YTD price-return overall performance of SKIN and peers Nu Skin Enterprises, Edgewell Personal Care plus Herbalife Nutrition, against SP500TR.
